Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Lipocine (LPCN) over the last 9 years, with Q3 2025 value amounting to $174208.0.

  • Lipocine's Interest & Investment Income fell 3632.14% to $174208.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $831474.0, marking a year-over-year decrease of 3146.22%. This contributed to the annual value of $1.1 million for FY2024, which is 1609.71% down from last year.
  • According to the latest figures from Q3 2025, Lipocine's Interest & Investment Income is $174208.0, which was down 3632.14% from $198637.0 recorded in Q2 2025.
  • Over the past 5 years, Lipocine's Interest & Investment Income peaked at $379521.0 during Q2 2023, and registered a low of $10649.0 during Q1 2021.
  • For the 5-year period, Lipocine's Interest & Investment Income averaged around $197498.5, with its median value being $225511.0 (2025).
  • Per our database at Business Quant, Lipocine's Interest & Investment Income tumbled by 8223.33% in 2021 and then soared by 122405.65% in 2022.
  • Quarter analysis of 5 years shows Lipocine's Interest & Investment Income stood at $22443.0 in 2021, then surged by 1224.06% to $297158.0 in 2022, then rose by 0.75% to $299379.0 in 2023, then fell by 22.13% to $233118.0 in 2024, then dropped by 25.27% to $174208.0 in 2025.
  • Its last three reported values are $174208.0 in Q3 2025, $198637.0 for Q2 2025, and $225511.0 during Q1 2025.